These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 15556688

  • 1. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J, Yamazaki K, Yokouchi H, Shinagawa N, Iwabuchi K, Nishimura M.
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [Abstract] [Full Text] [Related]

  • 2. Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells.
    van der Vliet HJ, Molling JW, Nishi N, Masterson AJ, Kölgen W, Porcelli SA, van den Eertwegh AJ, von Blomberg BM, Pinedo HM, Giaccone G, Scheper RJ.
    Cancer Res; 2003 Jul 15; 63(14):4101-6. PubMed ID: 12874013
    [Abstract] [Full Text] [Related]

  • 3. Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells.
    Imataki O, Heike Y, Makiyama H, Iizuka A, Ikarashi Y, Ishida T, Wakasugi H, Takaue Y.
    Cytotherapy; 2008 Jul 15; 10(5):497-506. PubMed ID: 18608348
    [Abstract] [Full Text] [Related]

  • 4. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
    Ueda N, Kuki H, Kamimura D, Sawa S, Seino K, Tashiro T, Fushuku K, Taniguchi M, Hirano T, Murakami M.
    Int Immunol; 2006 Sep 15; 18(9):1397-404. PubMed ID: 16914507
    [Abstract] [Full Text] [Related]

  • 5. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.
    Azuma T, Takahashi T, Kunisato A, Kitamura T, Hirai H.
    Cancer Res; 2003 Aug 01; 63(15):4516-20. PubMed ID: 12907625
    [Abstract] [Full Text] [Related]

  • 6. [Ex vivo expansion of Valpha24 natural killer T cells with alpha-galactosylceramide].
    Huang Y, Jiang EL, Zhou Z, He Y, Wang M, Liu QG, Zhai WJ, Han MZ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun 01; 27(3):315-20. PubMed ID: 16038267
    [Abstract] [Full Text] [Related]

  • 7. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S, Ishikawa A, Ishikawa E, Otsuji M, Iizasa T, Hanaoka H, Shimizu N, Horiguchi S, Okamoto Y, Fujii S, Taniguchi M, Fujisawa T, Nakayama T.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6079-86. PubMed ID: 17028247
    [Abstract] [Full Text] [Related]

  • 8. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
    Amanuma R, Nakajima T, Yoshie H, Yamazaki K.
    J Periodontal Res; 2006 Feb 15; 41(1):73-9. PubMed ID: 16409258
    [Abstract] [Full Text] [Related]

  • 9. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
    Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, Peters M, von Blomberg BM, Scheper RJ, van der Vliet HJ, van den Eertwegh AJ, Roelvink M, Beijnen J, Zwierzina H, Pinedo HM.
    Clin Cancer Res; 2002 Dec 15; 8(12):3702-9. PubMed ID: 12473579
    [Abstract] [Full Text] [Related]

  • 10. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A, Nieda M, Schmidt C, Koezuka Y, Ishihara S, Ishikawa Y, Tadokoro K, Durrant S, Boyd A, Juji T, Nicol A.
    Br J Cancer; 2001 Sep 01; 85(5):741-6. PubMed ID: 11531261
    [Abstract] [Full Text] [Related]

  • 11. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly.
    Peralbo E, DelaRosa O, Gayoso I, Pita ML, Tarazona R, Solana R.
    Biogerontology; 2006 Sep 01; 7(5-6):483-92. PubMed ID: 16953330
    [Abstract] [Full Text] [Related]

  • 12. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
    Jing Y, Gravenstein S, Chaganty NR, Chen N, Lyerly KH, Joyce S, Deng Y.
    Exp Gerontol; 2007 Aug 01; 42(8):719-32. PubMed ID: 17368996
    [Abstract] [Full Text] [Related]

  • 13. Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells.
    Imataki O, Heike Y, Ishida T, Takaue Y, Ikarashi Y, Yoshida M, Wakasugi H, Kakizoe T.
    J Immunother; 2006 Aug 01; 29(3):320-7. PubMed ID: 16699375
    [Abstract] [Full Text] [Related]

  • 14. Increased intratumor Valpha24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas.
    Tachibana T, Onodera H, Tsuruyama T, Mori A, Nagayama S, Hiai H, Imamura M.
    Clin Cancer Res; 2005 Oct 15; 11(20):7322-7. PubMed ID: 16243803
    [Abstract] [Full Text] [Related]

  • 15. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G, Berg M, Jüngerkes F, Diehl L, Sullivan BA, Kronenberg M, Limmer A, Knolle PA.
    Eur J Immunol; 2006 Mar 15; 36(3):570-82. PubMed ID: 16506291
    [Abstract] [Full Text] [Related]

  • 16. Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
    Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Van Kaer L, Saiki I, Okumura K.
    Eur J Immunol; 2001 Jun 15; 31(6):1720-7. PubMed ID: 11385616
    [Abstract] [Full Text] [Related]

  • 17. Activated CD1d-restricted natural killer T cells secrete IL-2: innate help for CD4+CD25+ regulatory T cells?
    Jiang S, Game DS, Davies D, Lombardi G, Lechler RI.
    Eur J Immunol; 2005 Apr 15; 35(4):1193-200. PubMed ID: 15770696
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 19. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
    Rogers PR, Matsumoto A, Naidenko O, Kronenberg M, Mikayama T, Kato S.
    J Immunol Methods; 2004 Feb 15; 285(2):197-214. PubMed ID: 14980434
    [Abstract] [Full Text] [Related]

  • 20. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
    Nicol A, Nieda M, Koezuka Y, Porcelli S, Suzuki K, Tadokoro K, Durrant S, Juji T.
    Immunology; 2000 Feb 15; 99(2):229-34. PubMed ID: 10692041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.